Spine Oncology Registry
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT07225491
- Status
- Recruiting
Conditions
- Spine Cancer
- Spine Metastases
- Spine Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is an observational study to evaluate hardware related and oncologic outcomes in adult patients with primary and metastatic spine disease undergoing separation surgery followed by radiation treatment.
Key Dates
- Start date
- Nov 24, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2035
- Completion
- Dec 31, 2037
Study Design
- Enrollment
- 3,000 participants (estimated)
Primary Outcome Measure
Overall survival [ Time Frame: 12, 18, 24 months ]
Central Contacts
- Courtney Wright6142934876
- Allison Garvin
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | Nicholas Szerlip Nicholas Szerlip, MD (PRINCIPAL_INVESTIGATOR) |
| Rutgers Robert wood Johnson Medical School | New Brunswick | New Jersey | 08901 | Christine Yohn Jonathan Sherman, MD (PRINCIPAL_INVESTIGATOR) |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | Allison Garvin Brad Elder, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
Related Studies
- Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral MetastasesPHASE2 · Recruiting · Case Comprehensive Cancer Center · Cleveland, Ohio
- Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine MetastasesRecruiting · Henry Ford Health System · Detroit, Michigan
- Stereotactic Magnetic Resonance Guided Radiation TherapyRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal ColumnRecruiting · Baptist Health South Florida · Miami, Florida